FibroGen, Inc.

FGEN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$48-$284-$294-$290
Dep. & Amort.$3$10$11$15
Deferred Tax$0$0$0$0
Stock-Based Comp.$25$51$66$71
Change in WC-$117-$120$70$60
Other Non-Cash-$1$28$1$62
Operating Cash Flow-$138-$315-$146-$82
Investing Activities
PP&E Inv.-$0-$3-$4-$5
Net Acquisitions$1$1$0$0
Inv. Purchases-$9-$252-$164-$484
Inv. Sales/Matur.$134$407$292$87
Other Inv. Act.$0$0-$35-$25
Investing Cash Flow$126$154$89-$427
Financing Activities
Debt Repay.-$0$74-$1-$6
Stock Issued$0$48$4$13
Stock Repurch.$0$0$0$0
Dividends Paid-$2$0$0$0
Other Fin. Act.$2$1$43-$7
Financing Cash Flow-$0$123$47-$1
Forex Effect$1-$3-$5$3
Net Chg. in Cash-$12-$42-$16-$507
Supplemental Information
Beg. Cash$114$156$171$678
End Cash$102$114$156$171
Free Cash Flow-$138-$318-$185-$112